BylineUmbhali: Jason Phillips
U-Rohit Kadam, PhD, usebenzise ngokucacileyo kwihlabathi ye-molecular diagnostics, kodwa ngaphandle kokufunda ubuchwepheshe elitsha kakhulu. Kwimeko, uqinisekisa ukuba izixhobo zonyango ezininzi ziyafumaneka kumadoda. Kwi-intersection of biology, public health, and product strategy, umsebenzi we-Dr. Kadam isetyenziselwa ukholelwa ukuba i-innovation yenzulululwazi olwenziwe ngexabiso okanye i-patent, kodwa yi-impact.
I-Mission Eyenziwe Nge-Equity, Akukho-Accolades
Ukutyala e-India kunye nokufunda e-USA, uDkt. Kadam waya kwi-science nge-curiosity kunye ne-purpose. Ukusetyenzisa ukuba izixhobo ze-healthcare ziyafumaneka ngempumelelo kunye ne-equality, ukuqhagamshelwano wayo kwi-academic kwi-biotech ayikho isikhokelo sokuba isikhokelo, kodwa isikhokelo se-moral. Uyacinga, "Ukuba i-science eyenza akuyona abathandi, ngoko ke siyenza?"
I-Academic Foundations, i-Real-World Ambitions
Ukususela umhla wokuqala, uDkt. Kadam wabhange ukuqhagamshelane ubugcisa yenzulululwazi kunye nemiphumo yobugcisa, inkxaso ebandakanya umzila wayo yenzulululwazi, kwaye ngoko ke, umzila wayo ye-biotech. Uthandwa i-PhD kwi-Biological Sciences kwi-Florida Institute of Technology kwaye uqhagamshelwano kwi-Phi Kappa Phi Honor Society for academic excellence.
Ukuphendula ukuvelisa i-theory yayo kwimeko, uDkt. Kadam waya kwi-academic research ukuya ku-biotech product management kunye nokufaka ukuvelisa i-innovation yenzululwazi ukusuka kwi-lab ukuya kwi-reel-world applications. Kwixesha elandelayo, uDkt. Kadam ufundise ukuvelisa kwimazwe omtsha kunye ne-educational landscape kunye nokufundisa ukuxhaswa kwe-scientific precision kunye ne-strategy ye-commercial xa uqhuba kwi-academic kwi-industry.
I-Dr. Kadam yaziwa ngokukhawuleza iimiphumo ezibonakalayo xa uqhagamshelane nophuhliso kunye ne-commercialization ye-qPCR ngexesha le-COVID-19 pandemic, ukunceda ukunciphisa iimfuno ze-diagnostic ehlabathini lonke.
Reimagining qPCR for the Real World
Ngexesha leCOVID-19 pandemic kunye nangaphezulu, uDkt. Kadam waya kwinxalenye ezininziI-Azure BiosystemsiimvelisoTakara Bio USAUkusetyenziswa kwe-QPCR kunye ne-reagents. Izixhobo zayo zilungele ekwenzeni izixhobo ze-diagnostic ezisiseko kwi-pandemic response global. Izixhobo zayo ziye zithunyelwe, zithunyelwe, kwaye zisetshenziswe kwihlabathi ngexesha le-Dr. Kadam ibonisa ukuba "i-science kufuneka ifumaneke ngokukhawuleza."
Yinto olungabonakaliweyo ibonisa amandla enkulu kaDkt. Kadam: umthamo wayo olungabonakaliyo ukuxhaswa uphando kunye ne-reality. Uyaziqhelekanga ukusetyenziswa kunye nokuphucula ukuba izixhobo zonyango ziquka i-intuitive, ezininzi, kunye ne-operational kwi-scale. Uyaziqhelekise lo mzekelo kunye ne-common-sense: ubuchwepheshe elikhulu ayinayo ukuba i-lab ayikwazi ukuqhuba ngexesha leMsombuluko kunye ne-half of its staff missing.
Ukuphumelela proactively iintloko zangaphambili: iingcebiso zempilo jikelele
Ngoku, uDkt. Kadam usebenzise ubuchwepheshe zokuhambaI-Antimicrobial Resistance(AMR), isixeko esifutshane kwi-global healthcare. Ngexesha lokuvelisa iimveliso yayo, uDkt. Kadam ivumela iilabhu ukucacisa iintlobo ezinxulumene ngokukhawuleza, ngokuvumelana nokuvimbela iziphumo ngaphambi kokufumana. It is not as headline-grabbing as COVID, kodwa uDkt.test enkulu yokufaneleka global.
U-Dr. Kadam utshintsho ukuqalisa i-non-profit diagnostics consultancy eyenza ukuba i-diagnostics ifumaneka kumazwe afanelekileyo ezincinane. Ufuna ukuchithwa kwe-innovation, ukubonisa ukuba ukufumanisa kwenzulululwazi akuyona kuxhomekeke kwi-cost of access. Njengoko ukhangela ngokubanzi, "i-test yokuqala ye-biotech ayikho yintoni enokwenzeka, kodwa ngubani inokunceda." Nge-track record eyenziwe kwimfuneko kunye nokwenza, uDkt.
